News & Views
Biotech Pioneer Appointed to Growing UK Life Science Company
Jan 31 2008
With a career spanning more than three decades as a senior researcher and manager in the pharmaceutical sector Ken Powell is widely acknowledged by the industry as one of its pioneers. His previous positions include CEO of Arrow Therapeutics, Head of Antiviral Research and Head of Biology at the Wellcome Foundation and Professor of Virology and Cell Biology at the Wolfson Institute for Biomedical Research at University College, London.
Ken Powell has an enviable record in founding and building life science start-ups. During his period of employment with the Wolfson Institute he helped establish Inpharmatica, now part of Galapagos NV and Ark Therapeutics which listed on the London Stock Exchangeâs main market in March 2004. Ken currently serves as the Head of Arrow Therapeutics, which he founded in 1998 and was acquired by Astra-Zeneca PLC for $150 million in February 2007.
Commenting on his appointment Ken Powell said âI have accepted the role of Executive Chairman of Q Chip for the simple reason I am excited by its prospects. It has undertaken some very exciting research, which provides the foundations for a strong pipeline of applications and products. The product opportunities presented by Q Chipâs technology will offer cost effective solutions to some of the most pressing issues in the biotech industry. I am particularly delighted to have the opportunity to assist Q Chip in the development of its MicroPlantTM drug delivery technology and expanding the commercial reach of its unique ReaX⢠range of easy to use, beaded molecular reagents.â
Digital Edition
International Labmate Buyers' Guide 2024/25
June 2024
Buyers' Guide featuring: Product Listings & Manufacturers Directory Chromatography Articles - Enhancing HPLC Field Service with fast-response, non-invasive flowmeters - Digital transformatio...
View all digital editions
Events
Jul 03 2024 Gandhinagar, India
Jul 07 2024 Dublin, Ireland
Jul 20 2024 Denver, CO, USA
Jul 21 2024 Cape Town, South Africa
Jul 28 2024 San Diego, CA USA